November 13, 2026 Audiometry identifies genetic loci linked to hearing loss Estimated genetic heritability was 11.8% using hearing thresholds versus 2.9% using diagnostic codes. MDSpire News
November 05, 2026 Medical Oddities: A needle in an abdominal haystack A needle goes missing, tea spills secrets, cells age, and dinner serves up a surprise this week. MDSpire News
October 29, 2026 FDA, CMS target gene therapy barriers FDA and CMS initiatives aim to simplify gene therapy approvals and expand access to treatments for rare diseases. MDSpire News
October 28, 2026 NUT carcinoma may defy typical staining patterns Two pulmonary cases highlight how limited squamous differentiation and variable keratin expression may complicate pathological diagnosis. MDSpire News
October 27, 2026 FDA expands talazoparib use in prostate cancer The combination with enzalutamide reduced the risk of radiographic progression or death by 52% . MDSpire News
October 26, 2026 Cryptococcal cellulitis may lead to amputation A splinter injury progressed to finger necrosis in a patient with MDS, despite antibacterial treatment and no clinically apparent systemic dissemination. MDSpire News
October 26, 2026 Vampire bats may link Chagas cycles Molecular screening detected Trypanosoma cruzi in 42% of sampled bats in northern Belize, raising questions about their role in parasite transmission. MDSpire News
October 23, 2026 FDA raises TMB threshold for pembrolizumab Traditional approval narrows eligibility for previously treated solid tumors after efficacy was not confirmed at lower biomarker levels. MDSpire News
October 19, 2026 FDA approves dostarlimab for advanced rectal cancer The accelerated approval adds an immunotherapy option for patients with MSI-H/dMMR stage II/III disease. MDSpire News
September 25, 2026 FDA monthly preview: Key October decisions to watch Several FDA decisions across multiple specialties are expected this month. MDSpire News